Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
February 5, 2025
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
June 30, 2021
Related Post
-
-
Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain
February 5, 2025
-
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
February 5, 2025
-
Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics
January 31, 2025